During the past decade, AZ Sint Elisabeth Herentals conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Sint Elisabeth Herentals" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Shire" with 2 trials sponsored, "Loxo Oncology, Inc." with 1 trials sponsored, "Materialise" with 1 trials sponsored and "Stryker Trauma GmbH" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Sint Elisabeth Herentals" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "End-of-Life Research Group" with 1 trials as a collaborator and "Universiteit Antwerpen" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "AZ Sint Elisabeth Herentals" are "Ulcerative Colitis" (5 trials), "Arthroplasty, Replacement, Shoulder" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Glenoid Cavity" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "AZ Sint Elisabeth Herentals" in a lesser frequency.

Most popular intervention types in "AZ Sint Elisabeth Herentals" are "Drug" (6 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etrolizumab" (2 trials), "Placebo" (2 trials), "225mg SHP647 (PF-00547659)" (1 trials), "75mg SHP647 (PF-00547659)" (1 trials) and "Bendamustine" (1 trials). Other intervention names were less common.

The vast majority of trials in "AZ Sint Elisabeth Herentals" are 10 trials for "All" genders.

Currently, there are NaN active trials in "AZ Sint Elisabeth Herentals". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in AZ Sint Elisabeth Herentals, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AZ Sint Elisabeth Herentals, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".